Two pre-grant oppositions filed by Panacea Biotech and Medecins Sans Frontieres (MSF) have been dismissed and a patent has been granted in favour of Wyeth for Prevnar 13. Published on Patents Rewind.
India has been in the centre of IP debate worldwide quite often and now another issue seemingly is making an entry i.e. Section 4 of the Indian Patents
The Assistant Controller of Patents and Designs on 7 November 2016 allowed two applications of Pfizer Ireland covering their commercial method for production of Etanercept, dismissing four pre-grant oppositions.
Due in part to its often-ambiguous requirements, Section 8 of India’s Patents Act has become a nightmare for patent owners, explains Pravin Anand. The 2009 Chemtura decision of
Pravin Anand and MS Bharath look at the seven important intellectual property tribunals in India and their function. Seven important tribunals dealing with intellectual property rights in India
Archana Shanker and Nupur Maithani consider what the battle over the Valcyte patent reveals about the Indian judiciary’s approach to pharmaceutical patents. The Valcyte patent has followed a
